This inventor holds 24 USPTO granted patents, primarily in Medical Electrode Technology. Top assignees: Pacesetter Ab, Siemens Elema Ab, Siemens Aktiengesellschaft. Active years: 1992-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Enskededalen, SE (1997)
- Stockholm, SE (2003)
- Enskede, SE (1992 - 2005)
Company Filing History:
12 out of 131 
6 out of 211 
4 out of 30,893 
Years Active: 1992-2005
Areas of Expertise:
Title: Innovations in Cardiac Technology: The Contributions of Ulf Lindegren
Introduction: Ulf Lindegren, located in Enskede, Sweden, is a remarkable inventor with a portfolio of 24 patents primarily focused on enhancing cardiac health technology. His innovative work has significantly contributed to the fields of cardiology and medical instrumentation, providing solutions that address critical health issues.
Latest Patents: Among his notable patents are two groundbreaking inventions. The first patent, titled "Method and circuit for detecting cardiac rhythm abnormalities by analyzing time differences between unipolar signals from a lead with a multi-electrode tip," presents a sophisticated technique for identifying cardiac rhythm issues. This method utilizes unipolar signals from a cardiac lead with multiple electrodes simultaneously in contact with the heart tissue. By analyzing the time relationship between these signals, it determines the presence of abnormalities or compares them to known templates representing dysfunctions.
The second patent, "Method for coating a tip region of a multipolar electrode lead," details an efficient way to apply a tissue-compatible coating, such as Titanium Nitride (TiN), to the tip of an electrode lead designed for heart stimulation. This innovation allows for a uniform coating of the conductive surfaces in a single step, enhancing the electrode's performance and longevity.
Career Highlights: Ulf Lindegren has an impressive career with notable contributions while working at reputable firms such as Pacesetter AB and Siemens Elema AB. His roles in these companies allowed him to leverage his expertise to develop advanced technologies that have had a positive impact on patient care and cardiac health management.
Collaborations: Throughout his career, Ulf has collaborated with esteemed colleagues, including Heinz Neubauer and Modesto Guerola. Their joint efforts have led to significant advancements in medical technologies, demonstrating the power of teamwork in fostering innovation.
Conclusion: Ulf Lindegren’s extensive patent work and collaborations have made him a key figure in the field of cardiac technology. His innovations not only enhance diagnostic and treatment methods but also contribute to better patient outcomes. As technology continues to evolve, Lindegren's contributions will undeniably play a crucial role in shaping the future of cardiac care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile